Middle East And Africa Arachidonic Acid Market By Technology (solvent Extraction And Solid Phase Extraction), Application Type (food And Pharmaceuticals), And Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and Rest of MEA) – Size, Share, Trends, Growth, Forecast (2025 to 2033)
The Arachidonic Acid Market size in the Middle East and Africa was valued at USD 0.29 billion in 2024 and is estimated to be worth USD 0.43 billion by 2033 from USD 0.31 billion in 2025, growing at a CAGR of 4.43% from 2025 to 2033
Arachidonic acid (ARA) is a long-chain omega-6 polyunsaturated fatty acid, plays a crucial role in cellular signaling and inflammatory responses. It is naturally synthesized in the human body but also sourced externally through diet or supplements, particularly in infant formulas, functional foods, and pharmaceuticals. In the Middle East and Africa (MEA), the demand for ARA has been increasingly linked to the region’s evolving healthcare infrastructure and growing emphasis on infant nutrition. As per recent data from the World Health Organization, over 30% of infants in sub-Saharan Africa are born with low birth weight, necessitating enhanced nutritional interventions, which in turn is boosting the adoption of ARA-enriched formulations. Additionally, rising awareness about early childhood development among urban populations in countries like Saudi Arabia and Egypt is further fueling product demand. According to the Food and Agriculture Organization, dietary supplementation trends in MEA have seen a year-over-year increase of nearly 8%, driven by regulatory support and rising disposable incomes.
One of the most significant drivers of the Middle East and Africa arachidonic acid market is the increasing focus on infant nutrition, especially in sub-Saharan African countries where malnutrition remains a persistent challenge. According to UNICEF, approximately 33% of children under five in this region suffer from stunted growth due to nutrient deficiencies. To combat this, governments and international aid organizations have ramped up initiatives promoting fortified infant formula, which often contains arachidonic acid as a key ingredient to support brain development and immune function.
In countries like Nigeria and Ethiopia, public health programs have partnered with global nutrition firms such as Nestlé and Danone to distribute ARA-enhanced baby products. The Global Nutrition Report 2023 noted that these efforts have contributed to a 12% rise in consumption of fortified infant nutrition products in sub-Saharan Africa over the past three years. Moreover, increased urbanization and improved access to healthcare services have led to higher consumer awareness regarding early childhood development needs. As a result, parents are more inclined to opt for premium infant formulas containing essential fatty acids like ARA.
Another major driver of the arachidonic acid market in the Middle East and Africa is the rapid expansion of the nutraceutical and functional food industries, particularly in the Gulf Cooperation Council (GCC) countries. Nations such as Saudi Arabia, the United Arab Emirates, and Qatar are witnessing a surge in demand for health-focused food products, driven by rising health consciousness and increasing disposable incomes. Arachidonic acid, known for its role in cognitive development and inflammatory response regulation, is being incorporated into a variety of enriched food and beverage products targeting health-conscious consumers.
A major restraint impeding the growth of the Middle East and Africa arachidonic acid market is the limited local production capacity and heavy dependence on imports. Unlike North America or Europe, where biotech fermentation facilities for ARA production are well-established, most MEA countries lack the industrial infrastructure necessary for large-scale synthesis of this fatty acid. This dependency not only increases procurement costs but also exposes the market to supply chain disruptions, fluctuating exchange rates, and import duties. For instance, in 2023, South Africa experienced a 22% increase in raw material costs due to currency devaluation, directly impacting the affordability of imported ARA for local manufacturers. Additionally, the absence of indigenous R&D initiatives and investment in biotechnological advancements limits the region's ability to develop cost-effective domestic alternatives.
Regulatory fragmentation across African markets presents another significant barrier to the expansion of the arachidonic acid market in the Middle East and Africa. Unlike the European Union or ASEAN, which maintain relatively harmonized food and supplement regulations, African countries operate under diverse and often inconsistent legal frameworks governing the approval and labeling of bioactive ingredients. As reported by the African Union’s Food Safety and Standards Initiative, only 18 out of 54 African nations have established clear regulatory guidelines for the use of omega-6 fatty acids like ARA in food products. For example, while Morocco and Kenya have adopted progressive policies allowing ARA fortification in infant formulas, neighboring countries such as Tanzania and Zambia still require extensive documentation and prolonged approval timelines before permitting commercial usage. According to the International Food Policy Research Institute, these delays can extend product launch periods by up to 18 months, significantly reducing market responsiveness.
An emerging opportunity in the Middle East and Africa arachidonic acid market lies in the growing interest in personalized nutrition, particularly in affluent Gulf economies. Consumers in countries like the United Arab Emirates and Kuwait are increasingly seeking tailored health solutions that align with their genetic profiles, lifestyle choices, and dietary preferences. Arachidonic acid, given its role in inflammation modulation and neural development, is being integrated into customized supplement regimens and medical foods designed for specific patient demographics. Dubai Health Authority has recently endorsed pilot programs incorporating biomarker-based dietary recommendations, encouraging private clinics and wellness centers to adopt advanced nutritional profiling tools. Furthermore, partnerships between regional biotech startups and global ingredient suppliers are facilitating the development of ARA-enriched formulations tailored to local metabolic profiles.
The rapid proliferation of e-commerce platforms across Africa is creating a new avenue for the growth of the arachidonic acid market. As internet penetration rises by reaching 50% in sub-Saharan Africa by 2023 according to the International Telecommunication Union consumers are increasingly turning to online marketplaces to purchase health and wellness products. A report by Disrupt Africa indicates that healthtech and nutraceutical e-commerce startups raised over $75 million in venture capital funding in 2023 alone, which is reflecting investor confidence in digital health distribution models.
This trend is particularly evident in urban centers such as Lagos, Nairobi, and Cape Town, where digital health platforms like Wellvis and Nourished Life offer direct-to-consumer supplements, including those fortified with essential fatty acids like ARA. These platforms provide detailed product education, dosage guidance, and even teleconsultations with nutritionists, thereby enhancing consumer trust and engagement. Moreover, mobile payment systems and logistics innovations have reduced barriers to access, enabling wider reach into semi-urban and rural areas.
One of the foremost challenges facing the Middle East and Africa arachidonic acid market is the high cost associated with ARA-enriched formulations in lower-income economies. Due to the complex fermentation and extraction processes required to produce arachidonic acid at scale, its inclusion in food and supplement products significantly elevates retail prices. For example, in countries like Ghana and Kenya, infant formulas fortified with ARA can cost up to 35% more than conventional alternatives, limiting accessibility for the majority of the population. Furthermore, in the Middle East, economic pressures in countries such as Egypt and Sudan have led to currency devaluation and inflationary spikes, exacerbating the price sensitivity of consumers.
Despite its physiological importance, consumer awareness regarding the benefits of arachidonic acid remains limited across much of the Middle East and Africa. This knowledge gap significantly hampers market penetration, particularly in rural and semi-urban regions where access to scientific information and healthcare education is constrained. According to a 2023 survey conducted by the African Academy of Sciences, less than 20% of respondents in West and Central Africa were familiar with the role of essential fatty acids in child development or immune function. In many communities, traditional beliefs and dietary habits continue to dominate consumer behavior, with minimal understanding of how bioactive compounds like ARA contribute to long-term health outcomes. Even in urban settings, marketing efforts by supplement and infant nutrition companies have been inconsistent, which is failing to create a cohesive narrative around the necessity of ARA-enriched products.
Efforts by non-governmental organizations and public health bodies have begun addressing this issue, but progress remains slow. For instance, the Nutrition Society of South Africa reported in 2023 that only 30% of community health workers had received formal training on lipid-based nutritional interventions, indicating a systemic deficiency in dissemination channels. Until targeted educational campaigns and public-private collaborations gain momentum, the market will struggle to achieve broad-based consumer acceptance.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 4.43% |
| Segments Covered | By Technology, Application Type, and Country |
| Various Analyses Covered | Regional and Country Level Analysis; Segment-Level Analysis; DROC; PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | KSA, UAE, Israel, the rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and the Rest of MEA |
| Market Leaders Profiled | Suntory, Cargill, Cabio Bioengineering, Cayman Chemicals, and A&Z Food additives CO. Ltd |
The solvent extraction segment was the largest and held a dominant share of the Middle East and Africa arachidonic acid market in 2024. One of the key drivers behind its dominance is the widespread availability of microbial fermentation facilities across the region, particularly in countries like Egypt and South Africa. According to a report by the African Biotechnology Stakeholders Forum, over 75% of existing biotech companies in these regions rely on solvent-based extraction due to lower capital investment and established operational protocols. Additionally, the lack of advanced infrastructure for more sophisticated methods such as supercritical fluid extraction limits the adoption of alternatives. Moreover, regulatory agencies in several MEA countries have already approved solvent extraction for commercial use, which accelerates product development timelines. The Egyptian Drug Authority, for instance, has certified over 15 local manufacturers using this technique in pharmaceutical-grade ARA production.
The Solid phase extraction (SPE) segment is likely to grow with a CAGR of 9.8% in the next coming years. One of the primary reasons for its accelerated growth is the rising demand for cleaner and more sustainable manufacturing processes within the nutraceutical and infant formula industries. In the UAE, where green manufacturing initiatives are supported under Vision 2030, companies like NutriLife and Arabian Bioactives have begun adopting SPE to meet stringent quality standards set by the Dubai Health Authority. Additionally, growing partnerships between international ingredient suppliers and local biotech firms are facilitating the transfer of advanced purification technologies into the MEA market.
The food industry segment was accounted in holding 58.3% of the Middle East and Africa arachidonic acid market share in 2024. One major factor fueling this trend is the rising prevalence of early childhood malnutrition in sub-Saharan Africa, where over 30% of children under five suffer from stunted growth, as reported by UNICEF. To combat this, governments in Ethiopia, Kenya, and Nigeria have implemented national nutrition programs promoting ARA-enriched baby products. For example, Ethiopia's National Nutrition Program has partnered with global brands like Nutricia and Wyeth to distribute fortified formulas in public health clinics. Another contributing element is the expanding middle-class population in Gulf Cooperation Council (GCC) countries, where consumer preferences are shifting toward health-conscious food choices. According to the Middle East Economic Survey, the UAE’s functional food sector grew by 11% in 2023, with ARA-fortified dairy and plant-based products seeing strong retail performance.
The pharmaceutical segment is more likely to gain huge traction with an anticipated CAGR of 10.2% during the forecast period. One key driver is the increasing incidence of chronic conditions such as diabetes and cardiovascular diseases across urban centers in South Africa, Egypt, and the GCC. According to the World Health Organization, non-communicable diseases now account for nearly 35% of all deaths in the African region, prompting pharmaceutical companies to explore lipid-based therapeutic interventions. In addition, regulatory bodies in Saudi Arabia and Israel are fast-tracking approvals for novel ARA-containing medications, accelerating their entry into the market. The Saudi Food and Drug Authority reported a 25% increase in registrations of omega-6-based drugs in 2023.
Saudi Arabia was accounted in holding 18.3% of the Middle East and Africa arachidonic acid market share in 2024. One of the main driving factors is the rapid expansion of the nutraceutical and infant nutrition sectors, supported by increasing disposable incomes and a growing emphasis on preventive healthcare. Additionally, pharmaceutical research institutions in Riyadh and Jeddah are actively exploring ARA’s applications in anti-inflammatory and cognitive health therapies. The King Abdullah City for Science and Technology reported in 2023 that multiple clinical studies were underway assessing the efficacy of ARA-based treatments for neurodegenerative conditions.
The UAE was positioned next in the Middle East and Africa arachidonic acid market with 15.3% of the share in 2024. A major growth catalyst is the flourishing personalized nutrition industry, where consumers are increasingly seeking tailored health solutions. Dubai Health Authority has been instrumental in promoting precision medicine, encouraging private clinics and wellness centers to integrate ARA-rich formulations into individualized treatment plans. Another critical factor is the presence of world-class manufacturing and logistics infrastructure, enabling efficient import and formulation of ARA-based products. The Jebel Ali Free Zone hosts several multinational health ingredient suppliers who cater to both domestic and pan-African markets.
South Africa is lucratively growing with fastest CAGR during the forecast period. One of the primary drivers is the growing focus on maternal and child nutrition, particularly in response to persistent malnutrition challenges. Government-backed initiatives such as the Integrated Nutrition Programme have facilitated wider distribution of fortified nutritional products in underserved communities. Additionally, the pharmaceutical industry in South Africa is evolving rapidly, with ARA being explored for its role in treating chronic inflammation and age-related diseases. The Medical Research Council of South Africa noted in 2023 that several academic institutions and private labs are investigating ARA derivatives for novel drug applications.
Egypt arachidonic acid market is likely to grow with prominent growth opportunities in the next coming years. One of the key growth enablers is the rising prevalence of lifestyle-related diseases, such as diabetes and obesity, which has led to greater interest in functional foods and supplements.
Kenya arachidonic acid market is swiftly emerging as a key growth center in East Africa. One of the primary growth drivers is the rising awareness among urban consumers regarding infant and maternal health. According to the Kenya National Bureau of Statistics, infant mortality rates have declined by 15% over the past decade, partly due to improved access to fortified nutrition products. Public-private partnerships, including those involving UNICEF and Nestlé, have significantly boosted the availability of ARA-enriched infant formulas in Nairobi and Mombasa. Additionally, the proliferation of e-commerce platforms offering health supplements is expanding market reach beyond traditional retail channels. Companies like Wellvis and MedPlus Kenya have reported a 20% year-over-year increase in sales of ARA-containing products, reflecting growing consumer engagement with online health solutions.
DSM is a global leader in nutritional ingredients and plays a pivotal role in shaping the arachidonic acid market, particularly through its advanced fermentation technologies and strong presence in infant nutrition formulations. The company supplies high-purity ARA to manufacturers across the Middle East and Africa, supporting the production of fortified baby formulas and dietary supplements. DSM’s emphasis on sustainable sourcing and innovation has positioned it as a trusted supplier in both pharmaceutical and food-grade applications.
BASF is a major player in the specialty chemicals sector and contributes significantly to the global arachidonic acid supply chain. In the MEA region, the company collaborates with local distributors and health product manufacturers to ensure a steady flow of ARA-based ingredients. Its extensive R&D capabilities and strategic partnerships with infant formula producers have reinforced its market standing. BASF’s commitment to quality and regulatory compliance makes it a preferred partner for regional nutraceutical firms.
Cargill operates across multiple sectors including food, agriculture, and health sciences, making it a key contributor to the arachidonic acid market in the Middle East and Africa. The company integrates ARA into functional food products and animal nutrition solutions tailored for emerging markets. Through its global supply network and localized distribution centers, Cargill ensures reliable access to essential fatty acids for both human and animal health applications in the region.
One of the primary strategies employed by leading players in the Middle East and Africa arachidonic acid market is strategic partnerships with local manufacturers, which is allowing multinational companies to navigate regulatory landscapes and enhance product accessibility. These collaborations help in customizing formulations to suit regional dietary preferences and healthcare needs.
Another widely adopted approach is expanding research and development initiatives focused on bioavailability, formulation stability, and application diversification. By investing in clinical studies and ingredient innovation, companies strengthen their product portfolios and reinforce scientific credibility in the eyes of consumers and regulators alike.
Lastly, enhancing supply chain resilience through regional logistics hubs is crucial for maintaining consistent product availability. Establishing warehousing and distribution centers in key locations like Dubai, Johannesburg, and Cairo enables faster delivery, reduces import dependencies, and supports market expansion across neighboring countries.
Major Players of the Middle East and Africa Arachidonic acid market include Suntory, Cargill, Cabio Bioengineering, Cayman Chemicals, and A&Z Food additives CO. Ltd
The competition in the Middle East and Africa arachidonic acid market is characterized by a mix of global ingredient suppliers and emerging regional players striving to capture market share through innovation and strategic positioning. While multinational corporations dominate due to their established supply chains and technical expertise, local firms are increasingly gaining traction by leveraging cost advantages and proximity to end-users. The market remains highly fragmented, especially in African nations where regulatory diversity and infrastructural limitations create entry barriers for smaller players. However, rising demand for fortified foods and pharmaceuticals is attracting new entrants, particularly in urbanized areas of the GCC and North Africa. Companies are focusing on product differentiation, collaborative ventures, and localized marketing efforts to establish stronger footholds.
This research report on the Middle East and Africa Arachidonic Acid Market has been segmented and sub-segmented based on technology, application type, and region.
By Technology
By Application Type
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region